Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
BioMed Research International
Volume 2014 (2014), Article ID 716538, 10 pages
http://dx.doi.org/10.1155/2014/716538
Review Article

Efficacy of Alendronate for Preventing Collapse of Femoral Head in Adult Patients with Nontraumatic Osteonecrosis

1Department of Emergency, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou 310008, China
2Department of Emergency, Research Institute of Emergency Medicine, Second Affiliated Hospital, School of Medicine, Zhejiang University, No. 88 Jiefang Road, Hangzhou 310009, China
3Department of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, No. 88 Jiefang Road, Hangzhou 310009, China

Received 5 June 2014; Accepted 9 September 2014; Published 11 November 2014

Academic Editor: Peng Zhang

Copyright © 2014 Yu-Cai Hong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Seamon, T. Keller, J. Saleh, and Q. Cui, “The pathogenesis of nontraumatic osteonecrosis,” Arthritis, vol. 2012, Article ID 601763, 10 pages, 2012. View at Publisher · View at Google Scholar
  2. M. A. Mont, T. M. Seyler, J. F. Plate, R. E. Delanois, and J. Parvizi, “Uncemented total hip arthroplasty in young adults with osteonecrosis of the femoral head: a comparative study,” The Journal of Bone and Joint Surgery Series A, vol. 88, supplement 3, pp. 104–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Mont, T. M. Seyler, D. R. Marker, G. A. Marulanda, and R. E. Delanois, “Use of metal-on-metal total hip resurfacing for the treatment of osteonecrosis of the femoral head,” The Journal of Bone and Joint Surgery A, vol. 88, supplement 3, pp. 90–97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. R. Marker, T. M. Seyler, M. S. McGrath, R. E. Delanois, S. D. Ulrich, and M. A. Mont, “Treatment of early stage osteonecrosis of the femoral head,” The Journal of Bone and Joint Surgery Series A, vol. 90, supplement 4, pp. 175–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Berry, W. S. Harmsen, M. E. Cabanela, and B. F. Morrey, “Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components,” The Journal of Bone and Joint Surgery Series A, vol. 84, no. 2, pp. 171–177, 2002. View at Google Scholar · View at Scopus
  6. L. D. Dorr, G. K. Takei, and J. P. Conaty, “Total hip arthroplasties in patients less than forty-five years old,” The Journal of Bone and Joint Surgery Series A, vol. 65, no. 4, pp. 474–479, 1983. View at Google Scholar · View at Scopus
  7. J. W. Pritchett, “Statin therapy decreases the risk of osteonecrosis in patients receiving steroids,” Clinical Orthopaedics and Related Research, no. 386, pp. 173–178, 2001. View at Google Scholar · View at Scopus
  8. G.-J. Wang, Q. Cui, and G. Balian, “The pathogenesis and prevention of steroid induced osteonecrosis,” Clinical Orthopaedics and Related Research, no. 370, pp. 295–310, 2000. View at Google Scholar · View at Scopus
  9. Y. Wang, L. Yin, Y. Li, P. Liu, and Q. Cui, “Preventive effects of puerarin on alcohol-induced osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 466, no. 5, pp. 1059–1067, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. J. Glueck, R. A. Freiberg, L. Sieve, and P. Wang, “Enoxaparin prevents progression of stages I and II osteonecrosis of the hip,” Clinical Orthopaedics and Related Research, no. 435, pp. 164–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Jäger, F. P. Tillmann, T. S. Thornhill et al., “Rationale for prostaglandin I2 in bone marrow oedema—from theory to application,” Arthritis Research and Therapy, vol. 10, no. 5, article R120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. C. Disch, G. Matziolis, and C. Perka, “The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost,” Journal of Bone and Joint Surgery B, vol. 87, no. 4, pp. 560–564, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-H. Chen, J.-K. Chang, K.-A. Lai, S.-M. Hou, C.-H. Chang, and G.-J. Wang, “Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study,” Arthritis and Rheumatism, vol. 64, no. 5, pp. 1572–1578, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K.-A. Lai, W.-J. Shen, C.-Y. Yang, C.-J. Shao, J.-T. Hsu, and R.-M. Lin, “The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis: a randomized clinical study,” The Journal of Bone and Joint Surgery Series A, vol. 87, no. 10, pp. 2155–2159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Nishii, N. Sugano, H. Miki, J. Hashimoto, and H. Yoshikawa, “Does alendronate prevent collapse in osteonecrosis of the femoral head?” Clinical Orthopaedics and Related Research, no. 443, pp. 273–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Agarwala and S. B. Shah, “Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years,” The Journal of Arthroplasty, vol. 26, no. 7, pp. 1128–1134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Agarwala, S. Shah, and V. R. Joshi, “The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years,” Journal of Bone and Joint Surgery Series B, vol. 91, no. 8, pp. 1013–1018, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Agarwala, D. Jain, V. R. Joshi, and A. Sule, “Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study,” Rheumatology, vol. 44, no. 3, pp. 352–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Agarwala, A. Sule, B. U. Pai, and V. R. Joshi, “Alendronate in the treatment of avascular necrosis of the hip,” Rheumatology, vol. 41, no. 3, pp. 346–347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Young, D. G. Little, and H. K. W. Kim, “Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease hip,” Clinical Orthopaedics and Related Research, vol. 470, no. 9, pp. 2462–2475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. B. Cardozo, D. M. S. Andrade, and M. B. Santiago, “The use of bisphosphonate in the treatment of avascular necrosis: a systematic review,” Clinical Rheumatology, vol. 27, no. 6, pp. 685–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-Q. Chen, B.-G. Sun, Y.-J. Cai, H.-M. Zhou, and J. Qin, “Clinical efficacy of alendronate treatment of early-stage adult nontraumatic avascular necrosis of femoral head,” Chinese Journal of Geriatrics, vol. 30, no. 8, pp. 661–663, 2011. View at Google Scholar
  23. G. J. Wang, D. B. Moga, W. G. Richemer, D. E. Sweet, S. I. Reger, and R. C. Thompson, “Cortisone induced bone changes and its response to lipid clearing agents,” Clinical Orthopaedics and Related Research, vol. 130, pp. 81–85, 1978. View at Google Scholar · View at Scopus
  24. G. J. Wang, D. E. Sweet, S. I. Reger, and R. C. Thompson, “Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits,” The Journal of Bone and Joint Surgery A, vol. 59, no. 6, pp. 729–735, 1977. View at Google Scholar · View at Scopus
  25. M. C. Vulpiani, M. Vetrano, D. Trischitta et al., “Extracorporeal shock wave therapy in early osteonecrosis of the femoral head: prospective clinical study with long-term follow-up,” Archives of Orthopaedic and Trauma Surgery, vol. 132, no. 4, pp. 499–508, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Hausdorf, A. Lutz, S. Mayer-Wagner, C. Birkenmaier, V. Jansson, and M. Maier, “Shock wave therapy for femoral head necrosis-Pressure measurements inside the femoral head,” Journal of Biomechanics, vol. 43, no. 11, pp. 2065–2069, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Ludwig, S. Lauber, H.-J. Lauber, U. Dreisilker, R. Raedel, and H. Hotzinger, “High-energy shock wave treatment of femoral head necrosis in adults,” Clinical Orthopaedics and Related Research, no. 387, pp. 119–126, 2001. View at Google Scholar · View at Scopus
  28. M. Ishida, M. Fujioka, K. A. Takahashi, Y. Arai, and T. Kubo, “Electromagnetic fields: a novel prophylaxis for steroid-induced osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 466, no. 5, pp. 1068–1073, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Seber, H. Omeroǧlu, H. Cetinkanat, and N. Köse, “The efficacy of pulsed electromagnetic fields used alone in the treatment of femoral head osteonecrosis: a report of two cases,” Acta Orthopaedica et Traumatologica Turcica, vol. 37, no. 5, pp. 410–413, 2003. View at Google Scholar · View at Scopus
  30. M. H. M. Harrison and C. A. L. Bassett, “The results of a double-blind trial of pulsed electromagnetic frequency in the treatment of Perthes' disease,” Journal of Pediatric Orthopaedics, vol. 17, no. 2, pp. 264–265, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. S.-L. Hsu, C.-J. Wang, M. S.-S. Lee, Y.-S. Chan, C.-C. Huang, and K. D. Yang, “Cocktail therapy for femoral head necrosis of the hip,” Archives of Orthopaedic and Trauma Surgery, vol. 130, no. 1, pp. 23–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C.-J. Wang, F.-S. Wang, K. D. Yang et al., “Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate,” Archives of Orthopaedic and Trauma Surgery, vol. 128, no. 9, pp. 901–908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. T. Drake, B. L. Clarke, and S. Khosla, “Bisphosphonates: mechanism of action and role in clinical practice,” Mayo Clinic Proceedings, vol. 83, no. 9, pp. 1032–1045, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. H. E. Jergeshn and A. S. Khan, “The natural history of untreated asymptomatic hips in patients who have non-traumatic osteonecrosis,” Journal of Bone and Joint Surgery Series A, vol. 79, no. 3, pp. 359–363, 1997. View at Google Scholar · View at Scopus
  35. J. P. T. Higgins, S. Green, and Cochrane Collaboration, Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Book Series, Wiley-Blackwell, Chichester, UK, 2008.
  36. B. Phillips, C. Ball, D. Sackett et al., Oxford Centre for Evidence-based Medicine—Levels of Evidence, March 2009.
  37. M. A. Mont, G. A. Marulanda, L. C. Jones et al., “Systematic analysis of classification systems for osteonecrosis of the femoral head,” The Journal of Bone and Joint Surgery Series A, vol. 88, supplement 3, pp. 16–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Baujat, C. Mahé, J.-P. Pignon, and C. Hill, “A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials,” Statistics in Medicine, vol. 21, no. 18, pp. 2641–2652, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. R. K. Sen, “Management of avascular necrosis of femoral head at pre-collapse stage,” Indian Journal of Orthopaedics, vol. 43, no. 1, pp. 6–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. D. S. Hungerford, “Treatment of osteonecrosis of the femoral head. Everything's new,” The Journal of Arthroplasty, vol. 22, no. 4, supplement 1, pp. 91–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Mont, M. G. Zywiel, D. R. Marker, M. S. McGrath, and R. E. Delanois, “The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review,” The Journal of Bone and Joint Surgery Series A, vol. 92, no. 12, pp. 2165–2170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. W. C. Hayes, M. Shea, and G. A. Rodan, “Preclinical evidence of normal bone with alendronate,” International Journal of Clinical Practice, Supplement, no. 101, pp. 9–13, 1999. View at Google Scholar · View at Scopus
  43. R. Merle D'Aubigné, M. Postel, A. Mazabraud, P. Massias, J. Gueguen, and P. France, “Idiopathic necrosis of the femoral head in adults,” The Journal of Bone and Joint Surgery Series B, vol. 47, no. 4, pp. 612–633, 1965. View at Google Scholar · View at Scopus
  44. E. S. Musso, S. N. Mitchell, M. Schink-Ascani, and C. A. Bassett, “Results of conservative management of osteonecrosis of the femoral head. A retrospective review,” Clinical Orthopaedics and Related Research, no. 207, pp. 209–215, 1986. View at Google Scholar · View at Scopus
  45. B. N. Stulberg, A. W. Davis, T. W. Bauer, M. Levine, and K. Easley, “Osteonecrosis of the femoral head: a prospective randomized treatment protocol,” Clinical Orthopaedics and Related Research, no. 268, pp. 140–151, 1991. View at Google Scholar · View at Scopus
  46. H. K. W. Kim, M. Sanders, S. Athavale, H. Bian, and F. Bauss, “Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral head,” Bone, vol. 39, no. 1, pp. 205–212, 2006. View at Publisher · View at Google Scholar · View at Scopus